9IU1 image
Deposition Date 2024-07-20
Release Date 2024-10-09
Last Version Date 2024-11-27
Entry Detail
PDB ID:
9IU1
Title:
Structure of SARS-CoV-2 JN.1 spike RBD in complex with ACE2 (up state)
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
4.30 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Processed angiotensin-converting enzyme 2
Gene (Uniprot):ACE2
Chain IDs:A
Chain Length:608
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Spike glycoprotein
Gene (Uniprot):S
Mutations:F817P, A892P, A899P, A942P, K986P, V987P, R682G, R683S, R685G
Chain IDs:B
Chain Length:1235
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Ligand Molecules
Primary Citation
Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1.
Nat Commun 15 8574 8574 (2024)
PMID: 39375326 DOI: 10.1038/s41467-024-52808-2

Abstact

Since 2019, SARS-CoV-2 has undergone mutations, resulting in pandemic and epidemic waves. The SARS-CoV-2 spike protein, crucial for cellular entry, binds to the ACE2 receptor exclusively when its receptor-binding domain (RBD) adopts the up-conformation. However, whether ACE2 also interacts with the RBD in the down-conformation to facilitate the conformational shift to RBD-up remains unclear. Herein, we present the structures of the BA.2.86 and the JN.1 spike proteins bound to ACE2. Notably, we successfully observed the ACE2-bound down-RBD, indicating an intermediate structure before the RBD-up conformation. The wider and mobile angle of RBDs in the up-state provides space for ACE2 to interact with the down-RBD, facilitating the transition to the RBD-up state. The K356T, but not N354-linked glycan, contributes to both of infectivity and neutralizing-antibody evasion in BA.2.86. These structural insights the spike-protein dynamics would help understand the mechanisms underlying SARS-CoV-2 infection and its neutralization.

Legend

Protein

Chemical

Disease

Primary Citation of related structures